The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

New data highlights an unprecedented crisis in National Health Service patient waiting lists and sheds light on how the ...

Today’s Forbes Daily newsletter covers Trump’s Fed chair candidates, Palantir’s rising share price, RFK cancels vaccine funding, GOP pushes for more on Epstein and more.

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

President Donald Trump has given major pharmaceutical companies 60 days to slash prescription drug prices or face action.

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

The announcement of a 15% tariff on pharmaceutical imports to the U.S. from the European Union may have not been the ideal ...

The White House cited data showing brand-name drugs in the United States are up to three times more expensive than identical drugs in other developed nations.

President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...